Cargando…

Strategies targeting angiogenesis in advanced non-small cell lung cancer

Tumor angiogenesis is a frequent event in the development and progression of non-small cell lung cancer (NSCLC) and has been identified as a promising therapeutic target. The vascular endothelial growth factor (VEGF) family and other angiogenic factors, including fibroblast growth factor and platele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jun, Chen, Jianpeng, Guo, Yan, Wang, Baocheng, Chu, Huili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581155/ https://www.ncbi.nlm.nih.gov/pubmed/28881856 http://dx.doi.org/10.18632/oncotarget.17957

Ejemplares similares

Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
por: Wang, Jun, et al.
Publicado: (2016)

Clinical Significance and Role of Lymphatic Vessel Invasion as a Major Prognostic Implication in Non-Small Cell Lung Cancer: A Meta-Analysis
por: Wang, Jun, et al.
Publicado: (2012)

Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer
por: Wang, Jun, et al.
Publicado: (2016)

Blood Vessel Invasion as a Strong Independent Prognostic Indicator in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Wang, Jun, et al.
Publicado: (2011)

Targeted therapies for advanced non-small cell lung cancer
por: Ai, Xiaojuan, et al.
Publicado: (2018)

Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis
por: Wang, Jun, et al.
Publicado: (2013)

p53 and angiogenesis in non-small-cell lung cancer.
por: Giatromanolaki, A., et al.
Publicado: (1998)

Interleukin‐36α suppresses growth of non‐small cell lung cancer in vitro by reducing angiogenesis
por: Xie, Xiaoxiao, et al.
Publicado: (2021)

Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
por: Scagliotti, Giorgio, et al.
Publicado: (2010)

Tumor angiogenesis as an important prognostic factor in advanced non-small cell lung cancer (Stage IIIA)
por: Bačić, Ivan, et al.
Publicado: (2018)

The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
por: Ren, Sijia, et al.
Publicado: (2021)

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer
por: Li, Shenduo, et al.
Publicado: (2023)

Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials
por: Zhao, Lingdi, et al.
Publicado: (2015)

Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
por: Rivas-Fuentes, Selma, et al.
Publicado: (2015)

Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer
por: Ge, Guanqun, et al.
Publicado: (2016)

Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer
por: Liang, Yan, et al.
Publicado: (2017)

Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer
por: Li, Yingying, et al.
Publicado: (2022)

Angiogenesis Inhibitors in Small Cell Lung Cancer
por: Montanino, Agnese, et al.
Publicado: (2021)

Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer
por: Zhang, Xiaofei, et al.
Publicado: (2023)

Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapy
por: Li, Kuo, et al.
Publicado: (2021)

Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer
por: Daoud, Alia, et al.
Publicado: (2017)

The Role of Anti-angiogenesis in the Treatment Landscape of Non-small Cell Lung Cancer – New Combinational Approaches and Strategies of Neovessel Inhibition
por: Daum, Sophia, et al.
Publicado: (2021)

Current immune therapeutic strategies in advanced or metastatic non-small cell lung cancer
por: Xu, Jing, et al.
Publicado: (2023)

Combination strategies of immunotherapy in non-small cell lung cancer: facts and challenges
por: Li, Chu-Ling, et al.
Publicado: (2021)

Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
por: Majeed, Umair, et al.
Publicado: (2021)

Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer
por: Zhang, Keqiang, et al.
Publicado: (2019)

Recent advances of novel targeted therapy in non-small cell lung cancer
por: Katzel, Jed A, et al.
Publicado: (2009)

Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumab
por: Stinchcombe, Thomas E
Publicado: (2007)

Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer
por: Wakelee, Heather, et al.
Publicado: (2018)

Prognosis prediction of icotinib as targeted therapy for advanced EGFR-positive non–small cell lung cancer patients
por: Tan, Xueyun, et al.
Publicado: (2023)

Identification of a prognostic immune‐related signature for small cell lung cancer
por: Xie, Qi, et al.
Publicado: (2021)

Long-term survival with targeted therapy in an advanced non-small cell lung cancer patient based on genetic profiling
por: Shen, Fang-Fang, et al.
Publicado: (2020)

Anti-angiogenesis target therapy for advanced osteosarcoma
por: Xie, Lu, et al.
Publicado: (2017)

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients
por: Nakashima, T, et al.
Publicado: (2003)

Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
por: Palumbo, Giuliano, et al.
Publicado: (2020)

Risk factors for radiation-induced lung injury in patients with advanced non-small cell lung cancer: implication for treatment strategies
por: Sha, Sha, et al.
Publicado: (2021)

Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer
por: Ma, Zijian, et al.
Publicado: (2021)

The resistance mechanisms and treatment strategies for EGFR-mutant advanced non-small-cell lung cancer
por: Zhong, Wen-Zhao, et al.
Publicado: (2017)

State-of-the-art combination treatment strategies for advanced stage non–small cell lung cancer
por: Yao, Yongfang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ko66n8e4uau0ei50netbpvi45